MedTrace Logo

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

NCT00863954 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-12-15

No results posted yet for this study

Summary

The purpose of this study is to see if using a device called the Resonator, that puts out a very low electromagnetic field, effects blood glucose and A1c levels in people with Type 2 Diabetes.

Conditions

  • Type II Diabetes Mellitus

Interventions

DEVICE

Resonator Device

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Sponsors & Collaborators

  • pico-tesla Magnetic Therapies, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00863954 on ClinicalTrials.gov